Research on killer HIV antibodies provides promising new ideas for vaccine design

By detailing the molecular workings of so-called broadly neutralizing anti-HIV antibodies, found in so-called slow-progressing HIV patients, researchers hope to devise a way to arm those who are not equipped with exceptional immunological firepower. New clues reveal that some anti-HIV antibodies are especially sticky and target a previously unrecognized part of the virus.

Read the whole article on The Rockefeller University

More from The Rockefeller University